|
Index of reports
> Cases with Abortion Spontaneous (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Edurant (Rilpivirine) where reactions include abortion spontaneous. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Edurant side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient:
Reactions: Cystic Lymphangioma, Maternal Exposure During Pregnancy, Abortion Spontaneous
Adverse event resulted in: death
Drug(s) suspected as cause:
Edurant
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Prezista
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Edurant side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient:
Reactions: Cystic Lymphangioma, Abortion Spontaneous
Adverse event resulted in: death
Drug(s) suspected as cause:
Edurant
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Prezista
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Edurant side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-01
Patient:
Reactions: Cystic Lymphangioma, Abortion Spontaneous
Adverse event resulted in: death
Drug(s) suspected as cause:
Edurant
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Prezista
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Edurant side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-27
Patient:
Reactions: Cystic Lymphangioma, Abortion Spontaneous
Adverse event resulted in: death
Drug(s) suspected as cause:
Edurant
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Prezista
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
|
